Biocompatible co-loading vehicles for delivering both nanoplatin cores and siRNA to treat hepatocellular carcinoma-Reference-Cited by-同舟云学术

Biocompatible co-loading vehicles for delivering both nanoplatin cores and siRNA to treat hepatocellular carcinoma

Published:2019-12 Issue: Volume:572 Page:118769
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Li Minsi,Zhao Pengxuan,Fan Ting,Chen Yan,Zhang Xiaojuan,He Chuanchuan,Yang Tan,Lee Robert J.,Khan Muhammad Waseem,Raza Shahid Masood,Ma Xiang,Lu Yao,Xiang Guangya

Funder

Natural Science Foundation of China

Independent Innovation Foundation of Higher Education of China

Huazhong University of Science and Technology

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. Cisplatin resistance and opportunities for precision medicine;Amable;Pharmacol. Res.,2016

2. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles;Ashley;ACS Nano,2011

3. Loss of BMI-1 expression is associated with clinical progress of malignant melanoma;Bachmann;Mod. Pathol.,2008

4. Joining forces: Bmi1 inhibition and cisplatin curb squamous carcinogenesis;Brown;Cell Stem Cell,2017

5. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade;Chen;Cancer Lett.,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticles Combining Gene Therapy and Chemotherapy as a Treatment for Gastrointestinal Tumors: A Systematic Review;Applied Sciences;2024-09-04

2. The Role of Small Interfering RNAs in Hepatocellular Carcinoma;Journal of Gastrointestinal Cancer;2023-07-11

3. Preparation of cisplatin delivery calcium phosphate nanoparticles using poly(Pt(IV) prodrug) as the payload;Materials Today Communications;2022-12

4. Dysregulation of non-coding RNAs mediates cisplatin resistance in hepatocellular carcinoma and therapeutic strategies;Pharmacological Research;2022-02

5. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma;Technology in Cancer Research & Treatment;2022-01